Where Abbott Laboratories Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 Wall Street analysts have provided their opinions on Abbott Laboratories (NYSE:ABT), with 3 giving a somewhat bullish rating and 1 indifferent. The average 12-month price target for ABT is $113.5, with a high of $121.00 and a low of $107.00, representing a 6.78% decrease from the previous target of $121.75. Analysts' ratings are based on company financials, meetings, and insider communications, and are updated quarterly or after major company events.
December 13, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Abbott Laboratories received mostly somewhat bullish ratings from analysts, with an average price target of $113.5, indicating a potential downside from the previous target.
The average price target represents a decrease from the previous target, which could suggest a tempered outlook on the stock's future performance. However, the majority of analysts are still somewhat bullish, and no bearish ratings were reported, which may mitigate any negative impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100